EXAGEN INC. - Common Stock, $0.001 Par Value Per Share (XGN)

CUSIP: 30068X103

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, $0.001 Par Value Per Share
Shares outstanding
24,382,838
Total 13F shares
6,285,386
Share change
+80,632
Total reported value
$11,440,080
Put/Call ratio
8%
Price per share
$1.82
Number of holders
32
Value change
+$146,598
Number of buys
11
Number of sells
12

Security key

30068X103

Report period

Q2 2024

Institutions

32

Top holders

10

Top shareholders of XGN - EXAGEN INC. - Common Stock, $0.001 Par Value Per Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RTW INVESTMENTS, LP
13F
Company
6.2%
1,504,602
$2,392,317 31 Mar 2024
13F
COWEN AND COMPANY, LLC
13F
Company
3.7%
898,630
$1,428,821 31 Mar 2024
13F
WASATCH ADVISORS LP
13F
Company
3.2%
786,895
$1,251,163 31 Mar 2024
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
2.2%
544,877
$866,354 31 Mar 2024
13F
PERKINS CAPITAL MANAGEMENT INC
13F
Company
2%
493,571
$785,000 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
2%
490,944
$780,601 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
2%
482,420
$767,048 31 Mar 2024
13F
Stonepine Capital Management, LLC
13F
Company
1.6%
384,600
$611,514 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.33%
81,583
$129,757 31 Mar 2024
13F
Penbrook Management LLC
13F
Company
0.31%
76,710
$121,969 31 Mar 2024
13F
Nantahala Capital Management, LLC
13F
Company
0.3%
74,306
$118,147 31 Mar 2024
13F
UBS Group AG
13F
Company
0.26%
62,516
$99,400 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
0.23%
55,505
$88,253 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.2%
48,758
$78,000 31 Mar 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.17%
40,800
$64,872 31 Mar 2024
13F
STATE STREET CORP
13F
Company
0.11%
27,691
$44,029 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.11%
26,437
$42,035 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.1%
23,860
$37,937 31 Mar 2024
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.08%
19,800
$31,482 31 Mar 2024
13F
Palumbo Wealth Management LLC
13F
Company
0.07%
18,241
$29,004 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.07%
16,370
$26,029 31 Mar 2024
13F
First Bank & Trust
13F
Company
0.06%
13,518
$21,494 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
7,240
$11,512 31 Mar 2024
13F
Allworth Financial LP
13F
Company
0.03%
7,015
$11,154 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
6,019
$9,570 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.02%
5,145
$8,181 31 Mar 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
4,006
$6,369 31 Mar 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
2,457
$3,906 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
0%
204
$324 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0%
34
$54 31 Mar 2024
13F
James L. L. Tullis
3/4/5
10%+ Owner
class O/S missing
1,543,155
$2,692,960 15 Jun 2023
Kamal Adawi
3/4/5
CFO and Corporate Secretary
class O/S missing
243,749
$465,536 04 Mar 2024
Mark Hazeltine
3/4/5
Chief Business Officer
class O/S missing
190,205
$331,927 02 Mar 2023
Fortunato R. Rocca
3/4/5
President and CEO, Director
class O/S missing
120,678
$210,595 01 Mar 2022
Debra Zack
3/4/5
Chief Medical Officer
class O/S missing
84,259
$147,040 01 Mar 2022
Brian Birk
3/4/5
Director
class O/S missing
9,000
$32,220 09 Jun 2023
Bruce C. Robertson
3/4/5
Director
class O/S missing
9,000
$32,220 17 Jun 2021
Ebetuel Pallares
3/4/5
Director
class O/S missing
9,000
$32,220 09 Jun 2023
Wendy S. Johnson
3/4/5
Director
class O/S missing
9,000
$32,220 09 Jun 2023

Institutional Holders of EXAGEN INC. - Common Stock, $0.001 Par Value Per Share (XGN) as of Q2 2024

As of 30 Jun 2024, EXAGEN INC. - Common Stock, $0.001 Par Value Per Share (XGN) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,285,386 shares. The largest 10 holders included RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, WASATCH ADVISORS LP, SILVERCREST ASSET MANAGEMENT GROUP LLC, PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, MORGAN STANLEY, Stonepine Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
30
Q2 2024 holders
32
Holder diff
2
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .